Total Acquires 25% Stake In Qatari Exploration Block

France's Total has acquired a 25% stake in Qatar's Block BC offshore exploration license, state-owned Qatar Petroleum said in a statement on Sunday.

Located 130 kilometers east of the Qatari coast, the offshore block covers an area of 5,649 square kilometers, with water depths ranging from 15 to 35 meters, it said.

China National Offshore Oil Company (CNOOC) Middle East Ltd., a wholly-owned subsidiary of CNOOC International Ltd., will continue to be the operator of the block with a 75% stake, according to the statement.

The agreement "is another step forward in the partnerships forged with QP and CNOOC, and reflects Total's commitment to expanding its exploration and production operations in promising geological basins," Christophe de Margerie, Chairman and Chief Executive Officer of Total, said in the statement.

Total also has a 10% interest in the Qatargas 1 LNG joint venture, as well as a 16.7% stake in Qatargas 2 Train 5 and a 24.5% stake in the Dolphin Energy Ltd company. Total's Qatari production averaged 164,000 barrels of oil equivalent per day in 2010, the statement said.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.